<Disease><Name>LESCH-NYHAN SYNDROME (HGPRT, HPRT)</Name><Synonym>HYPOXANTHIN GUANINE PHOSPHORIBOSYLTRANSFERASE; LESCH-NYHAN SYNDROME</Synonym><OMIM><Number>300322</Number><URL>http://omim.org/entry/300322</URL></OMIM><Orphanet><Number>510</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=510</URL></Orphanet><Protein><Number>Hypoxanthine-guanine phosphoribosyltransferase</Number><URL>http://www.uniprot.org/uniprot/P00492</URL></Protein><ExPASy><Number>2.4.2.8</Number><URL>http://enzyme.expasy.org/EC/2.4.2.8</URL></ExPASy><Gene>Xq26.2-q26.3</Gene><ICD>E79.1</ICD><Summary>rare (1:100000 males);X-linked ;mutations in HPRT1;complete: Lesch-Nyhan syndrome ;partial: Kelley-Seegmiller syndrome</Summary><Symptoms><symtomp><id>2347</id><symptom>anemia</symptom><category>IMMUNE OR HEMATOLOGIC SYSTEM | LABORATORY FINDINGS</category></symtomp><symtomp><id>1952</id><symptom>behavior, self-mutilating or destructive / behaviour, self-mutilating or destructive</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1945</id><symptom>chorea or athetosis</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2164</id><symptom>dysarthria</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2163</id><symptom>dysphagia</symptom><category>GASTROINTESTINAL SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1946</id><symptom>dystonia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1979</id><symptom>feeding difficulties, poor feeding</symptom><category>GASTROINTESTINAL SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1950</id><symptom>gout</symptom><category>ENDOCRINE SYSTEM | SKELETAL DEFECT</category></symtomp><symtomp><id>1882</id><symptom>growth retardation, poor growth</symptom><category>GENERAL TOPICS | GENERAL TOPICS</category></symtomp><symtomp><id>2274</id><symptom>hematuria</symptom><category>GENERAL TOPICS | GENITOURINARY TRACT</category></symtomp><symtomp><id>3926</id><symptom>hyperuricemia</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2275</id><symptom>infections (urinary tract)</symptom><category>GENITOURINARY TRACT | IMMUNE OR HEMATOLOGIC SYSTEM</category></symtomp><symtomp><id>3826</id><symptom>intellectual disability/intellectual developmental disorder</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2003</id><symptom>nephrosis</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>4101</id><symptom>renal failure, acute</symptom><category /></symtomp><symtomp><id>2461</id><symptom>renal failure, acute/chronic</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>2109</id><symptom>short stature</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1974</id><symptom>spastic diplegia/quadriplegia/tetraplegia</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2236</id><symptom>urolithiasis, nephrolithiasis, kidney stones</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>1980</id><symptom>vomiting</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp></Symptoms><Metabolites><metabolite><id>1671</id><name>Oxypurinol (Allopurinol-metabolite)</name><specimen>urine</specimen><value>normal/inc</value><min>5.10</min><max>29.30</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1839</id><name>Oxypurinol (Allopurinol-metabolite)</name><specimen>urine</specimen><value>normal/inc</value><min>19.00</min><max>37.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>739</id><name>Folate</name><specimen>serum</specimen><value>decreased</value><min>15.90</min><max>72.40</max><unit>nmol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>740</id><name>Folate</name><specimen>serum</specimen><value>decreased</value><min>4.10</min><max>20.40</max><unit>nmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>769</id><name>Hypoxanthin guanine phosphoribosyl transferase (HPRT)</name><specimen>fibroblasts</specimen><value>decreased</value><min>    </min><max>100.00</max><unit>% activity</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1536</id><name>Hypoxanthine</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>88.10</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>1537</id><name>Hypoxanthine</name><specimen>urine</specimen><value>increased</value><min>1.80</min><max>24.10</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1068</id><name>Hypoxanthine</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>71.90</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method>HPLC</method><comment /></metabolite><metabolite><id>1067</id><name>Hypoxanthine</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>10.00</max><unit>&#956;mol/l</unit><age>all</age><method /><comment /></metabolite><metabolite><id>1996</id><name>Hypoxanthine</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>71.90</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>451</id><name>Uric acid</name><specimen>urine</specimen><value>increased</value><min>527.00</min><max>790.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>1535</id><name>Uric acid</name><specimen>urine</specimen><value>increased</value><min>222.00</min><max>287.00</max><unit>mmol/mol creatinine</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>776</id><name>Uric acid</name><specimen>urine</specimen><value>increased</value><min>820.00</min><max>1026.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>417</id><name>Uric acid</name><specimen>serum</specimen><value>increased</value><min>120.00</min><max>350.00</max><unit>&#956;mol/l</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>1555</id><name>Xanthine</name><specimen>urine</specimen><value>increased</value><min>20.00</min><max>70.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>7324</id><title>Late diagnosis of Lesch-Nyhan disease complicated with end-stage renal disease and tophi burst: a case report</title><author>Ambarsari CG,</author><journal>Ren Fail</journal><year>2020</year><book /><volume>42</volume><number>1</number><pages>113-121</pages><co_aut>et al.</co_aut></literature><literature><id>7933</id><title>Description of the Lesch-Nyhan neurobehavioral disorder and its management through participant observation of three young individuals</title><author>Bozano A,</author><journal>JIMD Rep</journal><year>2020</year><book /><volume>52</volume><number>1</number><pages>63-71</pages><co_aut>et al.</co_aut></literature><literature><id>6975</id><title>Clinical, biochemical and genetic characteristics of a cohort of 101 French and Italian patients with HPRT deficiency</title><author>Madeo A,</author><journal>Mol Genet Metab</journal><year>2019</year><book /><volume>127</volume><number>2</number><pages>147-157</pages><co_aut>et al.</co_aut></literature><literature><id>7495</id><title>Macrocytic anemia in Lesch-Nyhan disease and its variants</title><author>Cakmakli HF,</author><journal>Genet Med</journal><year>2019</year><book /><volume>21</volume><number>2</number><pages>353-360</pages><co_aut>et al.</co_aut></literature><literature><id>6050</id><title>Inborn Errors of Metabolism with Cognitive Impairment: Metabolism Defects of Phenylalanine, Homocysteine and Methionine, Purine</title><author>Sklirou E,</author><journal>Pediatr Clin North Am</journal><year>2018</year><book /><volume>65</volume><number>2</number><pages>267-277</pages><co_aut>Lichter-Konecki U</co_aut></literature><literature><id>4725</id><title>A review of the implication of hypoxanthine excess in the physiopathology of Lesch-Nyhan disease</title><author>Torres RJ,</author><journal>Nucleosides Nucleotides Nucleic Acids</journal><year>2016</year><book /><volume>35</volume><number>10</number><pages>207-516</pages><co_aut>et al.</co_aut></literature><literature><id>4726</id><title>Lesch-Nyhan Syndrome: Models, Theories, and Therapies</title><author>Bell S,</author><journal>Mol Syndromol</journal><year>2016</year><book /><volume>7</volume><number>6</number><pages>302-311</pages><co_aut>et al.</co_aut></literature><literature><id>4727</id><title>Genotypic and phenotypic spectrum in attenuated variants of Lesch-Nyhan disease.</title><author>Fu R,</author><journal>Mol Genet Metab</journal><year>2014</year><book /><volume>112</volume><number>4</number><pages>280-285</pages><co_aut>Chen CJ, Jinnah HA</co_aut></literature><literature><id>4728</id><title>Lesch-Nyhan Syndrome</title><author>Nyhan WL,</author><journal>Source  GeneReviews&#174; [Internet]</journal><year>2014</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>2320</id><title>Eighteen-year follow-up of a patient with partial hypoxanthine phosphoribosyltransferase deficiency and a new mutation</title><author>Gregoric A</author><journal>Pediatr Nephrol</journal><year>2005</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>2321</id><title>Lesch-Nyhan Disease</title><author>Nyhan WL</author><journal>J Hist Neurosci</journal><year>2005</year><book /><volume>14</volume><number>1</number><pages>1-10</pages><co_aut /></literature><literature><id>2322</id><title>Hypothesized deficiency of guanine-based purines may contribute to abnormalities of neurodevelopment, neuromodulation, and neur</title><author>Deutsch SI</author><journal>Clin Neuropharmacol</journal><year>2005</year><book /><volume>28</volume><number>1</number><pages>28-37</pages><co_aut>et al.</co_aut></literature><literature><id>5950</id><title>Chemical diagnosis of Lesch-Nyhan syndrome using gas chromatography-mass spectrometry detection</title><author>Ohdoi C,</author><journal>J Chromatogr B Analyt Technol Biomed Life Sci</journal><year>2003</year><book /><volume>792</volume><number>1</number><pages>123-130</pages><co_aut>Nyhan WL, Kuhara T</co_aut></literature><literature><id>2318</id><title>The spectrum of hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency. Clinical experience based on 22 patients from</title><author>Puig JG</author><journal>Medicine (Baltimore)</journal><year>2001</year><book /><volume>80</volume><number>2</number><pages>102-112</pages><co_aut>et al.</co_aut></literature><literature><id>2319</id><title>New mutations of the HPRT gene in Lesch-Nyhan syndrome</title><author>Mak BS</author><journal>Pediatr Neurol</journal><year>2000</year><book /><volume>23</volume><number>4</number><pages>332-335</pages><co_aut>et al.</co_aut></literature><literature><id>2317</id><title>The recognition of Lesch-Nyhan syndrome as an inborn error of purine metabolism</title><author>Nyhan WL</author><journal>J Inherit Metab Dis</journal><year>1997</year><book /><volume>20</volume><number>2</number><pages>171-178</pages><co_aut /></literature><literature><id>96</id><title>Hypoxanthine-guanine phosphoribosyltransferase deficiency: Lesch-Nyhan syndrome and gout</title><author>Rossiter BJF</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>2</volume><number>0</number><pages>1679-1706</pages><co_aut>Caskey CT</co_aut></literature><literature><id>369</id><title>Disorders of purine and pyrimidine metabolism</title><author>van den Berghe G</author><journal>in Fernandes J, Saudubray JM, Tada K (eds): Inborn metabolic diseases, diagnosis and treatment; Berlin, Springer Verlag</journal><year>1990</year><book /><volume>0</volume><number>0</number><pages>455-474</pages><co_aut /></literature></Literatures></Disease>